Effects of consumption of the beverage containing fulvic acid and silicon on fatigue and sleep quality in healthy Japanese subjects who have received mRNA vaccination for COVID-19 at least three times - Trial UMIN000052180
Access comprehensive clinical trial information for UMIN000052180 through Pure Global AI's free database. This Not Applicable trial is sponsored by ORTHOMEDICO Inc. and is currently Recruiting. The study focuses on Healthy Japanese subjects.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000052180
Not Applicable
Recruiting
dietary supplement
Trial Details
University Hospital Medical Information Network • UMIN000052180
Effects of consumption of the beverage containing fulvic acid and silicon on fatigue and sleep quality in healthy Japanese subjects who have received mRNA vaccination for COVID-19 at least three times
Effects of consumption of the beverage containing fulvic acid and silicon on fatigue and sleep quality in healthy Japanese subjects who have received mRNA vaccination for COVID-19 at least three times: a randomized, placebo-controlled, parallel-group comparison study
Study Focus
Sponsor & Location
ORTHOMEDICO Inc.
Japan
Timeline & Enrollment
Not Applicable
Sep 12, 2023
N/A
ICD-10 Classifications
Japanese encephalitis
Data Source
University Hospital Medical Information Network
UMIN000052180
Non-Device Trial